Literature DB >> 8305419

Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.

K Kario1, T Miyata, T Sakata, T Matsuo, H Kato.   

Abstract

Factor VII (FVII) plays an important role in initiation of the tissue factor-induced coagulation pathway. An increase in FVII coagulant activity (FVIIc) has been proposed as an independent risk factor for coronary artery disease. However, it remains uncertain whether high FVIIc levels are due to an increase in the activation of FVII or an increase in the concentration of FVII mass. We developed a new fluorogenic assay for plasma activated FVII (FVIIa) that used soluble tissue factor. The sensitivity of this assay ranged from 0.2 to 1000 ng FVIIa per milliliter of plasma. Plasma FVIIa levels were measured in 110 healthy subjects and 93 patients with hypertension, diabetes mellitus, and/or cardiovascular disease. The mean plasma FVIIa level in healthy Japanese individuals was 2.5 ng/mL, which was lower than that in Western subjects. Gel filtration analysis showed that most of the circulating FVIIa was in a free form, and binding of FVIIa to tissue factor in plasma was not detected. Aging increased both the FVIIa level and FVII mass, whereas menopause increased mainly the FVII mass. Elderly patients with arterial cardiovascular diseases showed increases in plasma FVIIa levels and FVIIa to FVII antigen (FVII:Ag) ratios. Among the elderly, arterial cardiovascular disease was more common in a high-FVIIa than a low-FVIIa group. Plasma FVIIa levels were not correlated with serum levels of total cholesterol or triglycerides. The FVIIa level and the FVIIa-to-FVII:Ag ratio were positively correlated with fibrinogen level and negatively correlated with body mass index and serum albumin level in the elderly. In conclusion, aging, cardiovascular disease, and malnutrition increased plasma FVIIa levels. FVIIa levels were not correlated with lipid levels or hepatic synthesis, suggesting that FVIIa may be an independent risk factor for cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8305419     DOI: 10.1161/01.atv.14.2.265

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  6 in total

1.  Factor VII and incidence of myocardial infarction in a Japanese population: The Jichi Medical School Cohort Study.

Authors:  Takuya Shiraishi; Shizukiyo Ishikawa; Kazuomi Kario; Kazunori Kayaba; Eiji Kajii
Journal:  J Clin Lab Anal       Date:  2017-02-13       Impact factor: 2.352

2.  Is activated factor VII associated with retinal vein occlusion?

Authors:  S Kadayifçilar; D Ozatli; O Ozcebe; E C Sener
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

3.  Role of coagulation factor VII in pathogenesis of ischemic heart disease.

Authors:  Yu Hu; Danmei Xu; Chunyan Sun; Zhangbo Chu; Jin'e Zhen; Huafang Wang; Wenning Wei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

4.  The production of coagulation factor VII by adipocytes is enhanced by tumor necrosis factor-α or isoproterenol.

Authors:  N Takahashi; T Yoshizaki; N Hiranaka; O Kumano; T Suzuki; M Akanuma; T Yui; K Kanazawa; M Yoshida; S Naito; M Fujiya; Y Kohgo; M Ieko
Journal:  Int J Obes (Lond)       Date:  2014-12-15       Impact factor: 5.095

5.  Computational investigation of potential dosing schedules for a switch of medication from warfarin to rivaroxaban-an oral, direct Factor Xa inhibitor.

Authors:  Rolf Burghaus; Katrin Coboeken; Thomas Gaub; Christoph Niederalt; Anke Sensse; Hans-Ulrich Siegmund; Wolfgang Weiss; Wolfgang Mueck; Takahiko Tanigawa; Jörg Lippert
Journal:  Front Physiol       Date:  2014-11-07       Impact factor: 4.566

Review 6.  Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis.

Authors:  Francesco Bernardi; Guglielmo Mariani
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.